Table 1 Clinicopathological factors of 142 patients with Pan-NET.

From: MGMT is frequently inactivated in pancreatic NET-G2 and is associated with the therapeutic activity of STZ-based regimens

Characteristics

Total n = 142

Age, median (range)

57.5 (18–80)

Sex, male/female

72/70

Genetic syndrome, n (%)

12 (8.5)

 MEN type 1

10

 VHL

2

Lymphnode metastasis, n (%)

25 (17.6)

Liver metastasis, n (%)

41 (28.9)

 Synchronous

27 (19.0)

 Metachronous

14 (9.9)

Ki-67 index, median (range)

1.9 (0.07–33.5)

Mitosis, per 10HPF, median (range)

1 (0–25)

Tumor grade

 NET-G1

80

 NET-G2

56

 NET-G3

6

Specimen, origin

 Primary lesion (pancreas)

135

 Metastatic lesion (liver)

7

Specimen, procedure

 Operation

141

 Endoscopy (FNA)

1

Surgical procedue

 Pancreatectomy

116

 Hepatectomy ± pancreatectomy

26